| 000 | 00985 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250511185603.0 | ||
| 264 | 0 | _c19930205 | |
| 008 | 199302s 0 0 eng d | ||
| 022 | _a0940-1199 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRifkin, D B | |
| 245 | 0 | 0 |
_aPlasminogen activator expression and matrix degradation. _h[electronic resource] |
| 260 |
_bMatrix (Stuttgart, Germany). Supplement _c1992 |
||
| 300 |
_a20-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aExtracellular Matrix _xmetabolism |
| 650 | 0 | 4 |
_aFibrinolysin _xmetabolism |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aGrowth Substances _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xmetabolism |
| 650 | 0 | 4 |
_aPlasminogen Activators _xbiosynthesis |
| 773 | 0 |
_tMatrix (Stuttgart, Germany). Supplement _gvol. 1 _gp. 20-2 |
|
| 999 |
_c1486505 _d1486505 |
||